Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Change in Receivables (2024 - 2025)

Historic Change in Receivables for CG Oncology (CGON) over the last 2 years, with Q3 2025 value amounting to $238000.0.

  • CG Oncology's Change in Receivables rose 62888.89% to $238000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $663000.0, marking a year-over-year change of. This contributed to the annual value of $689000.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, CG Oncology's Change in Receivables is $238000.0, which was up 62888.89% from $217000.0 recorded in Q2 2025.
  • Over the past 5 years, CG Oncology's Change in Receivables peaked at $644000.0 during Q4 2024, and registered a low of -$436000.0 during Q1 2025.